Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscleR J Winquist, M A Napier, R L Vandlen, et al.
Cardiovascular Research|October 14, 2003
Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extractionJames C Hershey, Halea A Corcoran, Elizabeth P Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscleR J Winquist, L A Heaney, A A Wallace, et al.
Journal of Cardiovascular Pharmacology|September 11, 1991
Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscleE P Baskin, C M Serik, A A Wallace, et al.
Cardiovascular Research|February 13, 2001
Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesisJ C Hershey, E P Baskin, J D Glass, et al.
International Journal of Molecular Sciences|November 3, 2018
Ero1-Mediated Reoxidation of Protein Disulfide Isomerase Accelerates the Folding of Cone Snail ToxinsHenrik O'Brien, Shingo Kanemura, Masaki Okumura, et al.
Heart and Vessels|September 5, 2003
Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbitsJames C Hershey, Elizabeth P Baskin, Halea A Corcoran, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Cardiac electrophysiologic and antiarrhythmic actions of tedisamilA A Wallace, R F Stupienski, E P Baskin, et al.
Regulatory Peptides|February 1, 2005
Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assayJames C Hershey, Halea A Corcoran, Elizabeth P Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]J J Lynch, A A Wallace, R F Stupienski, et al.
Pageof 4